IBIO iBio, Inc.
NEUTRAL
Impact: 3/10
EFFECT
IPO/offering going effective
Final — all horizons settled through T+60d ⚠ clustered
IBIO ▼ -29.60% at T+60d
NEUTRAL call ✗ call lost -29.60% · α vs SPY -41.59% · entry $2.50 → $1.76
Last close $1.73 (close Jun 8) · -30.80% from $2.50 entry
T+1d
-4.80%
call -4.80% · α -4.62%
$2.38
settled 3mo ago
T+5d
-4.40%
call -4.40% · α -3.05%
$2.39
settled 3mo ago
T+20d
-15.60%
call -15.60% · α -12.79%
$2.11
settled 2mo ago
T+60d
-29.60%
call -29.60% · α -41.59%
$1.76
settled 7d ago
Price Chart
Loading chart...
Executive Summary
iBio, Inc. has received SEC effectiveness for its shelf registration statement on Form S-3, allowing the company to issue unspecified securities from time to time. This filing is administrative and does not disclose specific offering terms, size, or timing.
Actionable Insight
Monitor for future 8-K filings or prospectus supplements that may disclose actual offering details; shelf effectiveness creates flexibility but also a potential overhang on the stock.
Key Facts
- SEC has declared effective a shelf registration statement (Form S-3) for iBio, Inc. under file number 333-293864
- Effectiveness date was March 6, 2026, with filing accepted on March 9, 2026
- The filing is a general shelf registration, meaning iBio can now issue unspecified amounts of securities at its discretion over time
- No specific offering details (size, price, securities type) are disclosed in this EFFECT filing
Financial Impact
Potential future dilution or capital raise of unspecified size; no immediate financial impact
dilutionequitydebt
Risk Factors
- Future dilution risk if equity is issued at low prices
- Market perception of a potential near-term capital raise could pressure the stock
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000750 |
| Document: 9999999995-26-000750-index.html | 9999999995-26-000750 |
| Document: 9999999995-26-000750.txt | 9999999995-26-000750 |
9 reports for IBIO
67%
Hit rate
best @ T+20▲ +36.43%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 15, 2026
25d ago
|
3
| $1.47 $1.84 | ▲ +25.17% | ▲ +24.21% | $1.73 (+17.69%) |
|
May 12, 2026
28d ago
|
Press Release
| $1.55 $1.50 | ▲ +3.23% | ▲ +2.07% | $1.73 (−11.61%) |
|
May 8, 2026
4w ago
|
8-K
| $1.66 $1.42 | ▼ −14.46% | ▼ −14.37% | $1.73 (+4.22%) |
|
Apr 8, 2026
8w ago
|
8-K
| $2.24 $2.10 | ▼ −6.25% | ▼ −9.77% | $1.73 (−22.77%) |
|
Mar 19, 2026
11w ago
|
Insider Cluster
| $2.10 $1.74 | ▼ −17.14% | ▼ −14.93% | $1.73 (−17.62%) |
|
Mar 19, 2026
11w ago
|
Insider Cluster
| $2.10 $1.74 | ▼ −17.14% | ▼ −14.93% | $1.73 (−17.62%) |
|
Mar 16, 2026
12w ago
|
Press Release
| $2.46 $2.08 | ▼ −15.45% | ▼ −12.79% | $1.73 (−29.67%) |
|
Mar 9, 2026
13w ago
|
EFFECT
| $2.50 $2.39 | ▼ −4.40% | ▼ −3.05% | $1.73 (−30.80%) |
|
Feb 27, 2026
14w ago
|
S-3
| $2.69 $2.50 | ▲ +7.06% | ▲ +5.86% | $1.73 (+35.69%) |
Showing 9 of 9
US Market Status
Market Closed — Opens in 6h 14m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access